Correlation Between Solanbridge and Capricor Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Solanbridge and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Solanbridge and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Solanbridge Group and Capricor Therapeutics, you can compare the effects of market volatilities on Solanbridge and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Solanbridge with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Solanbridge and Capricor Therapeutics.

Diversification Opportunities for Solanbridge and Capricor Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Solanbridge and Capricor is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Solanbridge Group and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Solanbridge is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Solanbridge Group are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Solanbridge i.e., Solanbridge and Capricor Therapeutics go up and down completely randomly.

Pair Corralation between Solanbridge and Capricor Therapeutics

If you would invest  1,521  in Capricor Therapeutics on August 30, 2024 and sell it today you would earn a total of  383.00  from holding Capricor Therapeutics or generate 25.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy97.73%
ValuesDaily Returns

Solanbridge Group  vs.  Capricor Therapeutics

 Performance 
       Timeline  
Solanbridge Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Solanbridge Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Solanbridge is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Capricor Therapeutics 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Solanbridge and Capricor Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Solanbridge and Capricor Therapeutics

The main advantage of trading using opposite Solanbridge and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Solanbridge position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.
The idea behind Solanbridge Group and Capricor Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine